EVERGY INC (NASDAQ: EVRG) has reported earnings for its fourth fiscal quarter (ending December 31) of $0.25 versus $0.03 for the same period a year ago — an increase of 733%. However, this result fell […]
On 2/29/24, Catalyst Pharmaceutical Inc (NASDAQ: CPRX) stock enjoyed a major increase of 10.1%, closing at $16.03. Moreover, trading volume in this advance was exceptionally high at 282% of normal. The stock has risen 16.9% […]
For its fourth fiscal quarter (ending December 31), Biolife Solutions Inc (NASDAQ: BLFS) has reported E.P.S. of $-0.30 compared to $-1.15 a year ago. This performance was $-0.03 short of the consensus estimate of $-0.27. […]
On 2/29/24, Tongxin International Ltd (NASDAQ: TREE) stock enjoyed a major increase of 11.9%, closing at $39.57. Moreover, trading volume in this advance was exceptionally high at 213% of normal. Relative to the market the […]
Tile Shop Holdings Inc (NASDAQ: TTSH) has reported earnings for its fourth fiscal quarter (ending December 31) of $0.01 versus $0.03 for the same period a year ago — a decline of -67%. This result […]
Innoviva Inc (NASDAQ: INVA) has reported earnings for its fourth fiscal quarter (ending December 31) of $0.97 versus a loss $-0.98 for the same period a year ago. This result exceeded the consensus estimate of […]
Cogent Communications Holdings I (NASDAQ: CCOI) has reported earnings for its fourth fiscal quarter (ending December 31) of $4.23 versus $0.02 for the same period a year ago — an increase of 21050%. This result […]
Recent exceptional negative changes in investment behavior have affected Century Aluminum Co (NASDAQ: CENX): negative upside/downside volume developed, and its shorter term price trend turned down. Century Aluminum Co (NASDAQ: CENX) suffers from important negative […]
CRA International Inc (NASDAQ: CRAI) stock closed at $132.54 on 2/29/24 after a major increase of 12.3%. Moreover, this advance was accompanied by unusually high trading volume at 192% of normal. The stock has performed […]
On 2/29/24, Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) stock suffered a major decline of -14.9%, closing at $46.57. Moreover, this decline was accompanied by exceptionally high trading volume at 369% of normal. Relative to the market […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research